Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tree-Based Model for Thyroid Cancer Prognostication
Mousumi Banerjee, Daniel G. Muenz, Joanne T. Chang, et al.
The Journal of Clinical Endocrinology & Metabolism (2014) Vol. 99, Iss. 10, pp. 3737-3745
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

SVM–CART for disease classification
Evan L. Reynolds, Brian C. Callaghan, Mousumi Banerjee
Journal of Applied Statistics (2019) Vol. 46, Iss. 16, pp. 2987-3007
Open Access | Times Cited: 16
Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology
Theresa Vogel, Julia Wendler, Karin Frank‐Raue, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 6, pp. e2239-e2246
Open Access | Times Cited: 16
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case series
Viktoria Florentine Koehler, Carmina Teresa Fuß, Christina M. Berr, et al.
Clinical Endocrinology (2021) Vol. 96, Iss. 6, pp. 847-856
Open Access | Times Cited: 13
Optimal Differentiated Thyroid Cancer Management in the Elderly
Donald S.A. McLeod, Kelly Carruthers, Dev Kevat
Drugs & Aging (2015) Vol. 32, Iss. 4, pp. 283-294
Closed Access | Times Cited: 14
Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer
Keunyoung Kim, Kyoungjune Pak, In Joo Kim, et al.
Endocrine (2020) Vol. 70, Iss. 2, pp. 364-371
Closed Access | Times Cited: 13
Primary Care Provider Involvement in Thyroid Cancer Survivorship Care
Archana Radhakrishnan, David Reyes‐Gastelum, Brittany Gay, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 9, pp. e3300-e3306
Open Access | Times Cited: 13
Prognostic value of cancer antigen -125 for lung adenocarcinoma patients with brain metastasis: A random survival forest prognostic model
Hao Wang, Liuhai Shen, Jianhua Geng, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 14
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
Huapeng Lin, Lingfeng Zeng, Jing Yang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 11
Towards De-Implementation of low-value thyroid care in older adults
Jennifer M. Perkins, Maria Papaleontiou
Current Opinion in Endocrinology Diabetes and Obesity (2022) Vol. 29, Iss. 5, pp. 483-491
Open Access | Times Cited: 8
Clinical Significance of the Lymph Node Ratio of the Second Operation to Predict Re-Recurrence in Thyroid Carcinoma
Joonseon Park, Il Ku Kang, Ja Seong Bae, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 624-624
Open Access | Times Cited: 4
Fibronectin Contributes to a BRAF Inhibitor–driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2
Hannah M. Hicks, Nikita Pozdeyev, Sharon B. Sams, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 9, pp. 867-880
Open Access | Times Cited: 4
Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study
Qiang Ma, Zhiyuan Chen, Yi Fang, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 1, pp. 115-129
Closed Access | Times Cited: 4
Prognostic nomogram models for elderly patients with differentiated thyroid carcinoma: A population-based study
Dasong Wang, Yan Yang, Hongwei Yang, et al.
Medicine (2024) Vol. 103, Iss. 44, pp. e40381-e40381
Open Access | Times Cited: 1
Whole-exome sequencing enhances prognostic classification of myeloid malignancies
Matthew Ruffalo, Holleh Husseinzadeh, Hideki Makishima, et al.
Journal of Biomedical Informatics (2015) Vol. 58, pp. 104-113
Open Access | Times Cited: 11
Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram
Jianzhong Cao, Shengmin Lan, Liuhai Shen, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Treatment-Free Survival in Patients With Differentiated Thyroid Cancer
Mousumi Banerjee, David Reyes‐Gastelum, Megan R. Haymart
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 103, Iss. 7, pp. 2720-2727
Open Access | Times Cited: 11
Papillary thyroid carcinoma is a risk factor for severe osteoporosis
Masakazu Notsu, Mika Yamauchi, Miwa Morita, et al.
Journal of Bone and Mineral Metabolism (2019) Vol. 38, Iss. 2, pp. 264-270
Closed Access | Times Cited: 10
Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid Cancer
Ali S. Alzahrani, Yosra Moria, Noha Mukhtar, et al.
Journal of the Endocrine Society (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Physician Confidence in Neck Ultrasonography for Surveillance of Differentiated Thyroid Cancer Recurrence
Kevin J. Kovatch, David Reyes‐Gastelum, Jennifer A. Sipos, et al.
JAMA Otolaryngology–Head & Neck Surgery (2020) Vol. 147, Iss. 2, pp. 166-166
Open Access | Times Cited: 9
Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system
Ruyi Zhang, Mei Xu, Xiangxiang Liu, et al.
Endocrine (2021) Vol. 74, Iss. 1, pp. 108-119
Closed Access | Times Cited: 8
Network-guided prediction of aromatase inhibitor response in breast cancer
Matthew Ruffalo, Roby Thomas, Jian Chen, et al.
PLoS Computational Biology (2019) Vol. 15, Iss. 2, pp. e1006730-e1006730
Open Access | Times Cited: 6
Is BRAF V600E Mutation the Explanation for Age-Associated Mortality Risk in Patients With Papillary Thyroid Cancer?
Megan R. Haymart
Journal of Clinical Oncology (2017) Vol. 36, Iss. 5, pp. 433-434
Closed Access | Times Cited: 5
Controversies in the Management of Intermediate-Risk Differentiated Thyroid Cancer
David Toro-Tobón, Juan P. Brito
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 879-886
Closed Access
Survival trends and conditional survival in patients with pulmonary metastases from differentiated thyroid carcinoma
Xiaoyu Ji, Wei Sun, Chengzhou Lv, et al.
Endocrine (2024)
Closed Access
Real-World Use of Systemic Therapies for the Treatment of Advanced Thyroid Cancers
Debbie Chen, Mousumi Banerjee, Tianyi Xu, et al.
Endocrine Practice (2023) Vol. 29, Iss. 11, pp. 868-874
Closed Access | Times Cited: 1

Scroll to top